The Use of Acellular Dermal Matrix in Dupuytren Disease

  • Gloria R. Sue
  • Deepak NarayanEmail author



Recurrence following surgical treatment of Dupuytren disease remains a common problem. We hypothesize that the use of acellular dermal matrix is associated with decreased recurrence rates in Dupuytren disease.


We performed a retrospective cohort study of 43 patients undergoing open fasciectomy for Dupuytren disease from year 2005 to 2012 performed by a single surgeon at our academic institution. Standard fasciectomies of the affected palmar and digital fascia were performed via Bruner incision on all patients. Patients in one group had a sheet of acellular dermal matrix (Alloderm, LifeCell, Bridgewater, NJ) sutured into the surgical bed prior to closure, whereas patients in the control group were not closed with acellular dermal matrix. Patients were then evaluated at follow-up for disease recurrence, defined as presence of Dupuytren tissue in an area previously operated on, with a contracture greater than that recorded following the surgical fasciectomy.


Among our cohort of 43 patients, 23 (53.5 %) were treated with acellular dermal matrix while 20 (46.5 %) were not. The median age of our cohort was 66.5 years (range 54–91 years). The median follow-up was 1.8 years. During this follow-up period, recurrence of contracture was observed in 1 of 23 patients in the group of patients with acellular dermal matrix placed, compared to 5 of 20 in the control group (P = 0.045). No differences in the incidence of minor wound complications were observed.


We observed lower recurrence rates in the cohort of patients who were treated with placement of acellular dermal matrix into the wound bed following open fasciectomy for Dupuytren disease. Our novel technique has implications for future surgical treatment strategies to reduce recurrence rates in Dupuytren disease.


Acellular dermal matrix Contracture Dupuytren disease Hand surgery Recurrence Therapeutic intervention 


Conflict of Interest Declaration

The authors have no disclosures.


  1. Abe Y, Rokkaku T et al (2007) Clinical results of dermofasciectomy for Dupuytren’s disease in Japanese patients. J Hand Surg Eur Vol 32(4):407–410PubMedCrossRefGoogle Scholar
  2. Armstrong JR, Hurren JS et al (2000) Dermofasciectomy in the management of Dupuytren’s disease. J Bone Joint Surg Br 82(1):90–94PubMedCrossRefGoogle Scholar
  3. Brotherston TM, Balakrishnan C et al (1994) Long term follow-up of dermofasciectomy for Dupuytren’s contracture. Br J Plast Surg 47(6):440–443PubMedCrossRefGoogle Scholar
  4. Crean SM, Gerber RA et al (2011) The efficacy and safety of fasciectomy and fasciotomy for Dupuytren’s contracture in European patients: a structured review of published studies. J Hand Surg Eur Vol 36(5):396–407PubMedCrossRefGoogle Scholar
  5. Dupuytren G (1834) Clinical lectures on surgery. Lancet 23:56–59CrossRefGoogle Scholar
  6. Gilpin D, Coleman S et al (2010) Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren’s disease. J Hand Surg Am 35(12):2027–2038, e2021PubMedCrossRefGoogle Scholar
  7. Hall PN, Fitzgerald A et al (1997) Skin replacement in Dupuytren’s disease. J Hand Surg Br 22(2):193–197PubMedCrossRefGoogle Scholar
  8. Hamlin E Jr (1952) Limited excision of Dupuytren’s contracture. Ann Surg 135(1):94–97PubMedPubMedCentralCrossRefGoogle Scholar
  9. Heuston JT (1969) The control of recurrent Dupuytren’s contracture by skin replacement. Br J Plast Surg 22(2):152–156PubMedCrossRefGoogle Scholar
  10. Hueston JT (1962) Digital Wolfe grafts in recurrent Dupuytren’s contracture. Plast Reconstr Surg Transplant Bull 29:342–344PubMedCrossRefGoogle Scholar
  11. Hueston JT (1984) Dermofasciectomy for Dupuytren’s disease. Bull Hosp Jt Dis Orthop Inst 44(2):224–232PubMedGoogle Scholar
  12. Hurst LC, Badalamente MA et al (2009) Injectable collagenase clostridium histolyticum for Dupuytren’s contracture. N Engl J Med 361(10):968–979PubMedCrossRefGoogle Scholar
  13. Kelly SA, Burke FD et al (1992) Injury to the distal radius as a trigger to the onset of Dupuytren’s disease. J Hand Surg Br 17(2):225–229PubMedCrossRefGoogle Scholar
  14. Ketchum LD, Hixson FP (1987) Dermofasciectomy and full-thickness grafts in the treatment of Dupuytren’s contracture. J Hand Surg Am 12(5 Pt 1):659–664PubMedCrossRefGoogle Scholar
  15. Logan AM, Brown HG et al (1985) Radical digital dermofasciectomy in Dupuytren’s disease. J Hand Surg Br 10(3):353–357PubMedCrossRefGoogle Scholar
  16. Luck JV (1959) Dupuytren’s contracture; a new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg Am 41-A(4):635–664PubMedGoogle Scholar
  17. Peimer CA, Blazar P et al (2013) Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data. J Hand Surg Am 38(1):12–22PubMedCrossRefGoogle Scholar
  18. Rowley DI, Couch M et al (1984) Assessment of percutaneous fasciotomy in the management of Dupuytren’s contracture. J Hand Surg Br 9(2):163–164PubMedCrossRefGoogle Scholar
  19. Rudolph R (1979) Inhibition of myofibroblasts by skin grafts. Plast Reconstr Surg 63(4):473–480PubMedCrossRefGoogle Scholar
  20. Searle AE, Logan AM (1992) A mid-term review of the results of dermofasciectomy for Dupuytren’s disease. Ann Chir Main Memb Super 11(5):375–380PubMedCrossRefGoogle Scholar
  21. Stump A, Holton LH 3rd et al (2009) The use of acellular dermal matrix to prevent capsule formation around implants in a primate model. Plast Reconstr Surg 124(1):82–91PubMedCrossRefGoogle Scholar
  22. Tonkin MA, Burke FD et al (1984) Dupuytren’s contracture: a comparative study of fasciectomy and dermofasciectomy in one hundred patients. J Hand Surg Br 9(2):156–162PubMedCrossRefGoogle Scholar
  23. van der Veen VC, van der Wal MB et al (2010) Biological background of dermal substitutes. Burns 36(3):305–321PubMedCrossRefGoogle Scholar
  24. van Rijssen AL, ter Linden H et al (2012) Five-year results of a randomized clinical trial on treatment in Dupuytren’s disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg 129(2):469–477PubMedCrossRefGoogle Scholar
  25. Watt AJ, Curtin CM et al (2010) Collagenase injection as nonsurgical treatment of Dupuytren’s disease: 8-year follow-up. J Hand Surg Am 35(4):534–539, 539 e531PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Division of Plastic and Reconstructive Surgery, Department of SurgeryStanford University School of MedicinePalo AltoUSA
  2. 2.Section of Plastic and Reconstructive Surgery, Department of SurgeryYale University School of MedicineNew HavenUSA

Personalised recommendations